AbbVie's Allergan Aesthetics division has secured FDA approval for SKINVIVE by JUVÉDERM for improvement of neck appearance, marking the first filler indication specifically cleared for the neck in the U.S. market. The approval opens a new revenue stream in a category where practices have historically relied on off-label filler use, laser, or RF modalities.